Bluejay Diagnostics Management
Management criteria checks 4/4
Bluejay Diagnostics' CEO is Neil Dey, appointed in Mar 2024, has a tenure of less than a year. total yearly compensation is $292.15K, comprised of 97.6% salary and 2.4% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth $273.25. The average tenure of the management team and the board of directors is 3 years and 7.7 years respectively.
Key information
Neil Dey
Chief executive officer
US$292.2k
Total compensation
| CEO salary percentage | 97.6% |
| CEO tenure | less than a year |
| CEO ownership | 0.01% |
| Management average tenure | 3yrs |
| Board average tenure | 7.7yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$9m |
| Jun 30 2024 | n/a | n/a | -US$9m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$292k | US$285k | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$11m |
| Mar 31 2023 | n/a | n/a | -US$10m |
| Dec 31 2022 | US$425k | US$337k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$7m |
| Mar 31 2022 | n/a | n/a | -US$5m |
| Dec 31 2021 | US$182k | US$138k | -US$3m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$1m |
| Dec 31 2020 | US$21k | US$21k | -US$1m |
Compensation vs Market: Neil's total compensation ($USD292.15K) is below average for companies of similar size in the US market ($USD641.95K).
Compensation vs Earnings: Neil's compensation has been consistent with company performance over the past year.
CEO
Neil Dey (61 yo)
less than a year
Tenure
US$292,154
Compensation
Mr. Indranil Dey, also known as Neil, serves as the Chief Executive Officer, President and Director of Bluejay Diagnostics, Inc. and serves as its Principal Financial & Accounting Officer from March 29, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Principal Financial | less than a year | US$292.15k | 0.013% $ 273.2 | |
| Chief Technology Officer | 3.5yrs | US$240.29k | 0.0011% $ 23.2 | |
| Vice President of Operations | no data | no data | no data | |
| Chief Commercial Officer | no data | no data | no data | |
| Chief Medical Advisor | 3yrs | no data | no data | |
| Chief Medical Advisor | 3yrs | no data | no data |
3.0yrs
Average Tenure
61yo
Average Age
Experienced Management: BJDX's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Principal Financial | no data | US$292.15k | 0.013% $ 273.2 | |
| Independent Director | 8yrs | US$97.10k | 0.018% $ 369.5 | |
| Independent Director | 3.7yrs | US$82.10k | 0% $ 0 | |
| Independent Director | 3.2yrs | US$89.60k | 0% $ 0 | |
| Independent Chairman | 7.7yrs | US$109.60k | 0.077% $ 1.6k | |
| Director | 10yrs | US$62.10k | 0.00074% $ 15.3 |
7.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: BJDX's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 09:46 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bluejay Diagnostics, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Vandermosten | Zacks Small-Cap Research |